Skip to main content
Top
Published in: Cancer Causes & Control 4/2019

01-04-2019 | Breast Cancer | Original Paper

Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas

Authors: Parijatham S. Thomas, Caleb A. Class, Tanmay R. Gandhi, Arvind Bambhroliya, Kim-Anh Do, Abenaa M. Brewster

Published in: Cancer Causes & Control | Issue 4/2019

Login to get access

Abstract

Purpose

Identifying demographic, clinical, and geographical factors that contribute to disparities in the receipt of physician recommended chemotherapy in breast cancer patients.

Methods

The Texas Cancer Registry was used to identify women aged ≥ 18 years with invasive breast cancer diagnosed from 2007 to 2011 who received a recommendation for chemotherapy. Multivariable logistic regression was performed to determine associations between demographic and clinical factors and the receipt of chemotherapy. Cox proportional regression was used to estimate the hazard ratio (HR) for overall survival. Spatial analysis was conducted using Poisson models for breast cancer mortality and receipt of chemotherapy.

Results

Age ≥ 65 years, residence in areas with > 20% poverty index, and early disease stage were associated with lack of receipt of chemotherapy (all p < 0.001). Lack of receipt of chemotherapy was associated with decreased overall survival (HR 1.33, 95% CI 1.12–1.59, p = 0.001). A 38-county cluster in West Texas had lower receipt of chemotherapy (relative risk 0.88, p = 0.02) and increased breast cancer mortality (p = 0.03) compared to the rest of Texas.

Conclusion

Older age, increased poverty and rural geographical location are barriers to the receipt of chemotherapy. Interventions that target these barriers may reduce health disparities and improve breast cancer survival.
Literature
1.
go back to reference American Cancer Society (2018) Cancer Facts & Figs. 2018. American Cancer Society, Atlanta American Cancer Society (2018) Cancer Facts & Figs. 2018. American Cancer Society, Atlanta
2.
go back to reference Bambhroliya AB, Burau KD, Sexton K (2012) Spatial analysis of county-level breast cancer mortality in Texas. J Environ Public Health. 2012: 959343 Bambhroliya AB, Burau KD, Sexton K (2012) Spatial analysis of county-level breast cancer mortality in Texas. J Environ Public Health. 2012: 959343
3.
go back to reference Services TDoSH. Cancer incidence and mortality in Texas Services TDoSH. Cancer incidence and mortality in Texas
4.
go back to reference Hershman D, McBride R, Jacobson JS et al (2005) Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23:6639–6646CrossRefPubMed Hershman D, McBride R, Jacobson JS et al (2005) Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23:6639–6646CrossRefPubMed
5.
go back to reference Sineshaw HM, Freedman RA, Ward EM, Flanders WD, Jemal A (2015) Black/White disparities in receipt of treatment and survival among men with early-stage breast cancer. J Clin Oncol 33:2337–2344CrossRefPubMed Sineshaw HM, Freedman RA, Ward EM, Flanders WD, Jemal A (2015) Black/White disparities in receipt of treatment and survival among men with early-stage breast cancer. J Clin Oncol 33:2337–2344CrossRefPubMed
6.
go back to reference Gorin SS, Heck JE, Cheng B, Smith SJ (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244–2252CrossRefPubMed Gorin SS, Heck JE, Cheng B, Smith SJ (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244–2252CrossRefPubMed
7.
go back to reference Curtis E, Quale C, Haggstrom D, Smith-Bindman R (2008) Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112:171–180CrossRefPubMedPubMedCentral Curtis E, Quale C, Haggstrom D, Smith-Bindman R (2008) Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112:171–180CrossRefPubMedPubMedCentral
8.
go back to reference Griggs JJ, Hawley ST, Graff JJ et al (2012) Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. J Clin Oncol 30:3058–3064CrossRefPubMedPubMedCentral Griggs JJ, Hawley ST, Graff JJ et al (2012) Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. J Clin Oncol 30:3058–3064CrossRefPubMedPubMedCentral
9.
go back to reference Kulldorff M (1997) A spatial scan statistic. Commun Stat - Theor Methods 26:1481–1496CrossRef Kulldorff M (1997) A spatial scan statistic. Commun Stat - Theor Methods 26:1481–1496CrossRef
11.
go back to reference Dwass M (1957) Modified randomization tests for nonparametric hypotheses. Ann Math Stat 28:181–187CrossRef Dwass M (1957) Modified randomization tests for nonparametric hypotheses. Ann Math Stat 28:181–187CrossRef
14.
go back to reference Kurian AW, Lichtensztajn DY, Keegan TH et al (2013) Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004–2007. Breast Cancer Res Treat 137:247–260CrossRefPubMed Kurian AW, Lichtensztajn DY, Keegan TH et al (2013) Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004–2007. Breast Cancer Res Treat 137:247–260CrossRefPubMed
15.
go back to reference Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE (2018) Socioeconomic status and breast cancer treatment. Breast Cancer Res Treat 167:1–8CrossRefPubMed Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE (2018) Socioeconomic status and breast cancer treatment. Breast Cancer Res Treat 167:1–8CrossRefPubMed
16.
go back to reference Bhargava A, Du XL (2009) Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer 115:2999–3008CrossRefPubMedPubMedCentral Bhargava A, Du XL (2009) Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer 115:2999–3008CrossRefPubMedPubMedCentral
18.
go back to reference Oncology TASoC (2017) The state of cancer care in America, 2017: a report by the American society of clinical oncology. J Oncol Pract 13:e353–e394CrossRef Oncology TASoC (2017) The state of cancer care in America, 2017: a report by the American society of clinical oncology. J Oncol Pract 13:e353–e394CrossRef
20.
go back to reference Lin CC, Bruinooge SS, Kirkwood MK et al (2015) Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance. J Clin Oncol 33:3177–3185CrossRefPubMedPubMedCentral Lin CC, Bruinooge SS, Kirkwood MK et al (2015) Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance. J Clin Oncol 33:3177–3185CrossRefPubMedPubMedCentral
21.
go back to reference Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM (2014) Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer. NC Med J 75:239–246 Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM (2014) Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer. NC Med J 75:239–246
22.
go back to reference Jhaveri D, Larkins S, Kelly J, Sabesan S (2016) Remote chemotherapy supervision model for rural cancer care: perspectives of health professionals. Eur J Cancer Care 25:93–98CrossRef Jhaveri D, Larkins S, Kelly J, Sabesan S (2016) Remote chemotherapy supervision model for rural cancer care: perspectives of health professionals. Eur J Cancer Care 25:93–98CrossRef
23.
go back to reference Sabesan S, Larkins S, Evans R et al (2012) Telemedicine for rural cancer care in North Queensland: bringing cancer care home. Aust J Rural Health 20:259–264CrossRefPubMed Sabesan S, Larkins S, Evans R et al (2012) Telemedicine for rural cancer care in North Queensland: bringing cancer care home. Aust J Rural Health 20:259–264CrossRefPubMed
24.
go back to reference Ko NY, Darnell JS, Calhoun E et al (2014) Can patient navigation improve receipt of recommended breast cancer care? Evidence from the national patient navigation research program. J Clin Oncol 32:2758–2764CrossRefPubMedPubMedCentral Ko NY, Darnell JS, Calhoun E et al (2014) Can patient navigation improve receipt of recommended breast cancer care? Evidence from the national patient navigation research program. J Clin Oncol 32:2758–2764CrossRefPubMedPubMedCentral
Metadata
Title
Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas
Authors
Parijatham S. Thomas
Caleb A. Class
Tanmay R. Gandhi
Arvind Bambhroliya
Kim-Anh Do
Abenaa M. Brewster
Publication date
01-04-2019
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 4/2019
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-019-01151-9

Other articles of this Issue 4/2019

Cancer Causes & Control 4/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine